Proqr Therapeutics Is A Biotechnology Company Focused On Developing Rna Therapies For Severe Rare And Common Diseasesfounded In 2012 By Daniel Ade Boer And His Co Foundersthe Company Is Headquartered In Leidenthe Netherlandswith An Additional Office In Cambridgemassachusettsusaproqr S Mission Is To Provide Treatment Options For Patients With Rare Diseases That Currently Lack Effective Therapies The Company Utilizes Its Proprietary Axiomera C Rna Editing Platform Technologywhich Employs The Cell S Own Editing Machinery To Make Precise Edits In Rnathis Innovative Approach Aims To Reverse Mutations Or Modulate Protein Expressionpotentially Leading To New Medicines For Diseases With Significant Unmet Needsproqr Is Dedicated To Advancing Its Pipeline Of Rna Therapiestargeting Conditions That Have Limited Or No Existing Treatmentsproqr Therapeutics Is Publicly Traded On The Nasdaq Under The Ticker Symbol Prqr And Actively Engages In The Biotechnology Community Through Conferences And Events
No conferences found for this company.
| Company Name | Proqr Therapeutics Nv |
| Country |
Netherlands
|
| Address | N/A |
| Telephone | N/A |
| N/A |
